治疗反应的血清代谢量在严重肌痛性肌痛症
Patricia Sikorski1,2, Yaoxiang Li3, Mehar Cheema1
1Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, United States of America.
PloS one
|October 10, 2023
概括
研究人员在肌痛性骨髓灰质炎 (MG) 患者中发现了新的生物标志物,这些生物标志物可以预测对普得尼松治疗的反应. 这一发现可能会导致针对MG的个性化皮质类固醇治疗,改善非响应者的结果.
科学领域:
- *神经免疫学和临床神经学.
- * 代谢学和脂质学.
- * 发现自身免疫性疾病的生物标志物.
背景情况:
- *高剂量的普雷尼松是肌痛性肌痛症 (MG) 的首要治疗方法,但大约三分之一的患者没有反应.
- * 目前,没有可靠的生物标志物可以预测患者对皮质类固醇治疗的反应.
- * 识别预测生物标志物对于优化MG治疗策略至关重要.
研究的目的:
- * 发现血清生物标志物,可以预测肌痛严重症 (MG) 患者对普得尼松的临床反应.
- *使用MGTX临床试验中的代谢和脂质组概况来识别生物标志物.
- *为了将基线血清概况与六个月后的治疗反应相关联.
主要方法:
- *从MGTX试验的血清样本使用超高性能液态染色学和质谱学进行了分析.
- * 在进入研究时进行了代谢和脂质分析的比较.
- * 用经过验证的措施评估治疗反应,包括最小表现状态 (MMS),MG-日常生活活动 (MG-ADL) 和定量MG (QMG) 评分.
主要成果:
- *血清脂的增加与治疗反应相关 (QMG,MMS,响应者分类).
- *一个预测小组 (histidine,自由脂肪酸 (13:0),γ-cholestenol,guanosine) 实现了治疗响应的AUC为0.90.
- *路径分析表明,异生菌代谢在治疗耐药性方面起着作用.
结论:
- * 已确定一种特定的代谢和脂质组概况作为MG皮质类固醇治疗反应的潜在预测标记.
- * 对于不同的结果指标而言,不同的代谢概况表明了独特的生物学基础.
- * 普得尼松代谢的个体间变化可能会影响MG患者的治疗疗效.
更多相关视频
02:55Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
Published on: October 6, 2023
1.4K
13:56The Use of Magnetic Resonance Spectroscopy as a Tool for the Measurement of Bi-hemispheric Transcranial Electric Stimulation Effects on Primary Motor Cortex Metabolism
Published on: November 19, 2014
20.2K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
929
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
929
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Serum Studies: Renal Function Tests
9
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
